Inventor
CAMPBELL PATRICIA S
US24 patents
Patents
24 patentsUS4816258AMar 28, 1989
Transdermal contraceptive formulations
ALZA CORP188 citations99
US4704282ANov 3, 1987
Transdermal therapeutic system having improved delivery characteristics
ALZA CORP181 citations99
US4379454AApr 12, 1983
Dosage for coadministering drug and percutaneous absorption enhancer
ALZA CORP586 citations99
US5342623AAug 30, 1994
Subsaturated transdermal therapeutic system having improved release characteristics
ALZA CORP144 citations98
US4908027AMar 13, 1990
Subsaturated transdermal therapeutic system having improved release characteristics
ALZA CORP174 citations98
US6512010B1Jan 28, 2003
Formulations for the administration of fluoxetine
ALZA CORP76 citations97
US6324424B1Nov 27, 2001
Reduction of skin irritation during electrotransport delivery
ALZA CORP42 citations96
US5990179ANov 23, 1999
Composition and method of enhancing electrotransport agent delivery
ALZA CORP59 citations96
US5840327ANov 24, 1998
Transdermal drug delivery device having enhanced adhesion
ALZA CORP78 citations96
US4867982ASep 19, 1989
Transdermal drug delivery device
ALZA CORP62 citations96
US4725439AFeb 16, 1988
Transdermal drug delivery device
ALZA CORP68 citations96
US4460372AJul 17, 1984
Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
ALZA CORP120 citations96
US5462745AOct 31, 1995
Subsaturated transdermal therapeutic system having improved release characteristics
ALZA CORP72 citations95
US5344656ASep 6, 1994
Subsaturated transdermal therapeutic system having improved release characteristics
ALZA CORP62 citations95
US5512293AApr 30, 1996
Oral sustained release drug delivery device
ALZA CORP129 citations94
US4832953AMay 23, 1989
Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
ALZA CORP100 citations94
US6007837ADec 28, 1999
Drug delivery devices and process of manufacture
ALZA CORP70 citations93
US7011844B2Mar 14, 2006
Formulations for the administration of fluoxetine
ALZA CORP29 citations92
US6572879B1Jun 3, 2003
Formulations for transdermal delivery of pergolide
ALZA CORP19 citations92
US6001390ADec 14, 1999
Formulations for transdermal delivery of pergolide
ALZA CORP41 citations92
US5693010ADec 2, 1997
Reduction of skin irritation during electrotransport delivery
ALZA CORP22 citations92
US5985316ANov 16, 1999
Composition and method of enhancing electrotransport agent delivery
ALZA CORP14 citations74
US5865792AFeb 2, 1999
Reduction of skin irritation during electrotransport delivery
ALZA CORP10 citations74
US6174545B1Jan 16, 2001
Drug delivery devices and process of manufacture
ALZA CORP9 citations71